Randomized Clinical Trial
Copyright ©The Author(s) 2023.
World J Hepatol. Jun 27, 2023; 15(6): 826-840
Published online Jun 27, 2023. doi: 10.4254/wjh.v15.i6.826
Table 6 Outcomes and reasons of readmission characteristics by randomization arms, n (%)

Intervention (n = 120)
Standard of care (n = 120)
P value
Readmission
    No77, 64.1782, 68.330.59
    Yes43, 35.8338, 31.67
Number of readmissions within 30 d
    077, 64.17 82, 68.33 0.65
    131, 25.8332, 26.67
    29, 7.505, 4.17
    32, 1.671, 0.83
    51, 0.830, 0.00
Location of 1st readmission
    Our institution 36, 83.7223, 60.530.03
    Outside hospital7, 16.2815, 39.47
Reason for 1st readmission1
    Acute kidney injury10, 23.266, 15.790.58
    Hyponatremia4, 9.306, 15.790.50
    Hepatic encephalopathy9, 20.9317, 44.740.03
    Volume overload13, 30.239, 23.680.62
    Variceal bleed6, 13.956, 15.791.00
    Lower GI bleed1, 2.333, 7.890.34
    Spontaneous bacterial peritonitis2, 4.651, 2.631.00
    Other20, 46.5122, 57.890.37
Index admission cost (mean ± SD, n = 116 + 109)61581 ± 4782559547 ± 466690.46
Index admission LOS (mean ± SD)8.17 ± 5.568.08 ± 6.110.63
First readmission LOS (n = 43 + 38, mean ± SD)7.58 ± 7.578.71 ± 10.410.58
All readmissions LOS (n = 60 + 45, mean ± SD)9.28 ± 16.888.69 ± 10.440.82
Waiting time for first readmission (n = 43 + 38, mean ± SD)11.16 ± 7.1014.34 ± 7.770.06